Safety Study of Albuterol Spiromax® in Subjects With Asthma

Study Title
Safety Study of Albuterol Spiromaxֲ® in Subjects With Asthma
Teva Identifier
ABS-AS-307
ClinicalTrials.gov Identifier
NCT01698320
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Placebo MDPI | Drug: Albuterol MDPI
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations
respiratory-icon

Key Participation Requirements

Gender
Female, Male
Age group
Child, Adult, Older Adult
Age Range
12 Years and older
Trial Duration
10/01/2012 - 12/01/2013
Phase
Phase 3

Study Type

Interventional